SARAH KIM: Open Payments
NPI 1083264766 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 26 payments from 13 companies in 2025. Trend: 2023 $1,548 · 2024 $233 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $187 |
| REVANCE THERAPEUTICS, INC. | 1 | $108 |
| Neurocrine BioSciences, Inc. | 3 | $83 |
| Xeris Pharmaceuticals, Inc. | 4 | $81 |
| BETA BIONICS, INC. | 2 | $38 |
| Botanix SB Inc | 1 | $26 |
| UCB, Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| Eton Pharmaceuticals, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
Products named: Sogroya, DAXI, CRENESSITY, GVOKE HYPOPEN, iLet Bionic Pancreas, SOFDRA, Bimzelx, Wegovy.
Industry payments across TX — which companies pay providers there.
